Table 5.
Univariate HR (95% CI) | Multivariate HR (95% CI) |
||||||
---|---|---|---|---|---|---|---|
Deaths/Cases | Basea | Base + Surgeryb | Base + Surgery + Radiotherapyc | Base + Surgery + Radiotherapy + First Course Non-TMZ Chemod | Base + Surgery + Radiotherapy + First Course Non-TMZ Chemo + First Course TMZ Chemoe | ||
Full cohort: 1618 deaths/1645 cases | |||||||
Period of diagnosis | |||||||
1997–2000 | 516/518 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
2001–2004 | 582/586 | 0.96 (0.85–1.08) | 0.91 (0.80–1.02) | 0.91 (0.81–1.03) | 0.92 (0.81–1.04) | 0.91 (0.80–1.03) | 1.06 (0.93–1.21) |
2005–2008 | 520/541 | 0.82 (0.73–0.93) | 0.72 (0.64–0.82) | 0.70 (0.62–0.80) | 0.74 (0.65–0.84) | 0.73 (0.64–0.83) | 1.01 (0.86–1.19) |
Period effect P | .0040 | <.0001 | <.0001 | <.0001 | <.0001 | .60 | |
Trend P | .0015 | <.0001 | <.0001 | <.0001 | <.0001 | .84 | |
Restricted cohort (treated with resection and radiotherapy): 910 deaths/932 cases | |||||||
Period of diagnosis | |||||||
1997–2000 | 303/305 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
2001–2004 | 324/327 | 0.87 (0.75–1.02) | 0.81 (0.69–0.95) | 0.81 (0.69–0.95) | 0.81 (0.69–0.96) | 0.80 (0.68–0.94) | 1.05 (0.87–1.25) |
2005–2008 | 283/300 | 0.71 (0.60–0.83) | 0.60 (0.51–0.71) | 0.61 (0.52–0.73) | 0.62 (0.52–0.73) | 0.60 (0.51–0.72) | 1.02 (0.79–1.31) |
Period effect P | .0002 | <.0001 | <.0001 | <.0001 | <.0001 | .86 | |
Trend P | <.0001 | <.0001 | <.0001 | <.0001 | <.0001 | .86 |
Abbreviations: Chemo, chemotherapy; CI, confidence interval; HR, hazard rate ratio; TMZ, temozolomide.
aAdjusted for age at diagnosis (≤39 y, 40–44, 45–49, … 80–84, 85+) and baseline Charlson comorbidity score (0, ≥1, unknown).
bAdditionally adjusted for surgery (biopsy only, partial resection, gross total resection, resection not otherwise specified), modeled as a time-updated covariate.
cAdditionally adjusted for radiotherapy (no, yes, unknown), modeled as a time-updated covariate.
dAdditionally adjusted for first course non-TMZ chemotherapy (no, yes, unknown), modeled as a time-updated covariate.
eAdditionally adjusted for first course TMZ chemotherapy (no, yes, unknown), modeled as a time-updated covariate.